FFCP PHASE2:Hg19::chr14:54863682..54863738,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@CDKN3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_CDKN3_5end |
Coexpression cluster: | C3434_prostate_Reticulocytes_mucinous_epidermoid_testis_teratocarcinoma_chronic |
Association with transcript: | 0bp_to_ENST00000442975, ENST00000458126, ENST00000543789, ENST00000556102_5end |
EntrezGene: | CDKN3 |
HGNC: | 1791 |
UniProt: | G3V1K6G3V2J7 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@CDKN3 |
---|
0
50
100
150
200
250
300
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 6.29e-47 | 235 |
disease of cellular proliferation | 2.76e-45 | 239 |
cell type cancer | 1.25e-23 | 143 |
organ system cancer | 1.80e-23 | 137 |
carcinoma | 3.47e-20 | 106 |
hematologic cancer | 3.77e-16 | 51 |
immune system cancer | 3.77e-16 | 51 |
leukemia | 5.78e-12 | 39 |
myeloid leukemia | 1.34e-08 | 31 |
disease of anatomical entity | 1.79e-07 | 39 |
Showing 1 to 10 of 10 entries